Tensha Therapeutics
Small molecule selective bromodomain inhibitors for treating cancer and other diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$535m (Public information from Jan 2016)
Cambridge Massachusetts (HQ)
Authorizing premium user...